Saiag, P., Robert, C., Grob, J. J., Mortier, L., Dereure, O., Lebbe, C., Mansard, S., Grange, F., Neidhardt, E., Lesimple, T., Machet, L., Bedane, C., Jeudy, G., Aubin, F., Dreno, B., Szenik, A., Denden, A., & Dutriaux, C. (n.d.). 1260PAn open-label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib for patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095480287.0x000035